MMP2 and prostate cancer: During prostate cancer progression the level of enzymes involved in metastasis, uPA, MMP-2, and MMP-9, displayed increased levels in the dorsolateral prostate of TRAMP mice, but the intake of apigenin downregulated their levels, which led to a “complete absence” of the metastasis [117].